Literature DB >> 16247603

Effect of diazepam on the efficacy of dual-phase FDG PET imaging.

Hongming Zhuang, R Hustinx, A Alavi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16247603     DOI: 10.1007/s00259-005-1957-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  13 in total

1.  Advantage of delayed whole-body FDG-PET imaging for tumour detection.

Authors:  K Kubota; M Itoh; K Ozaki; S Ono; M Tashiro; K Yamaguchi; T Akaizawa; K Yamada; H Fukuda
Journal:  Eur J Nucl Med       Date:  2001-06

2.  Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck.

Authors:  R Hustinx; R J Smith; F Benard; D I Rosenthal; M Machtay; L A Farber; A Alavi
Journal:  Eur J Nucl Med       Date:  1999-10

3.  Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer.

Authors:  A R Boerner; M Weckesser; H Herzog; T Schmitz; W Audretsch; U Nitz; H G Bender; H W Mueller-Gaertner
Journal:  Eur J Nucl Med       Date:  1999-03

4.  Effect of pretreatment with vitamin E or diazepam on brain metabolism of stressed rats.

Authors:  A A Shaheen; M A Hamdy; A A Kheir-Eldin; P Lindström; A A el-Fattah
Journal:  Biochem Pharmacol       Date:  1993-07-06       Impact factor: 5.858

5.  FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT.

Authors:  Kazuo Kubota; Jyunkichi Yokoyama; Keiichiro Yamaguchi; Shuichi Ono; Ahmad Qureshy; Masatoshi Itoh; Hiroshi Fukuda
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-01-14       Impact factor: 9.236

6.  Effects of anticonvulsants on GLUT1-mediated glucose transport in GLUT1 deficiency syndrome in vitro.

Authors:  Jörg Klepper; Anne Flörcken; Jorge Fischbarg; Thomas Voit
Journal:  Eur J Pediatr       Date:  2002-12-06       Impact factor: 3.183

7.  Potentiation of lonidamine and diazepam, two agents acting on mitochondria, in human glioblastoma treatment.

Authors:  L Miccoli; F Poirson-Bichat; F Sureau; R Bras Gonçalves; Y Bourgeois; B Dutrillaux; M F Poupon; S Oudard
Journal:  J Natl Cancer Inst       Date:  1998-09-16       Impact factor: 13.506

8.  Restaging of recurrent cervical carcinoma with dual-phase [18F]fluoro-2-deoxy-D-glucose positron emission tomography.

Authors:  Chyong-Huey Lai; Kuan-Gen Huang; Lai-Chu See; Tzu-Chen Yen; Chien-Sheng Tsai; Ting-Chang Chang; Hung-Hsueh Chou; Koon-Kwan Ng; Swei Hsueh; Ji-Hong Hong
Journal:  Cancer       Date:  2004-02-01       Impact factor: 6.860

Review 9.  [Targeting the gene of glucose metabolism for the treatment of advanced gliomas].

Authors:  S Oudard; L Miccoli; B Dutrillaux; M F Poupon
Journal:  Bull Cancer       Date:  1998-07       Impact factor: 1.276

10.  Assessment of single-dose benzodiazepines on insulin secretion, insulin sensitivity and glucose effectiveness in healthy volunteers: a double-blind, placebo-controlled, randomized cross-over trial [ISRCTN08745124].

Authors:  Hugues Chevassus; Isabelle Mourand; Nathalie Molinier; Bruno Lacarelle; Jean-Frédéric Brun; Pierre Petit
Journal:  BMC Clin Pharmacol       Date:  2004-03-04
View more
  3 in total

1.  In vitro antiproliferative characteristics of flavonoids and diazepam on SNU-C4 colorectal adenocarcinoma cells.

Authors:  Sang-Woo Lee; Jae-Tae Lee; Maan-Gee Lee; Ho Won Lee; Sohn Joo Ahn; Yong Jin Lee; You La Lee; Jeongsoo Yoo; Byeong-Cheol Ahn; Jeoung-Hee Ha
Journal:  J Nat Med       Date:  2008-12-03       Impact factor: 2.343

2.  The increment in standardized uptake value determined using dual-phase 18F-FDG PET is a promising prognostic factor in non-small-cell lung cancer.

Authors:  Helen H W Chen; Bi-Fang Lee; Wu-Chou Su; Yu-Hsuan Lai; Hung-Yu Chen; How-Ran Guo; Wei-Jen Yao; Nan-Tsing Chiu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-06-07       Impact factor: 9.236

3.  Use of benzodiazepines before (18)F-FDG-PET/CT dual-phase imaging does not decrease the efficacy of the study.

Authors:  Filiz Ozülker; Tamer Ozülker; Tevfik Ozpaçacı
Journal:  Indian J Nucl Med       Date:  2012-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.